ESDE 2017
Thursday 9 November 2017
Esophageal Oncology
Grote Zaal

08.30 - 10.30 Optimizing neoadjuvant treatment in esophagogastric cancer
  Chairs: T. Walsh, H. van Laarhoven

08.30-08.45 Diagnostic Markers for Neoadjuvant therapy
  G. Bakker
08.45-09.00 Radiation dose, fractionation and volume considerations in the preoperative treatment
  K. Haustermans
09.00-09.15 Neoadjucant Chemotherapy vs Chemoradiotherapy
  J. Reynolds
09.15-09.30 The ICONIC trial, perioperative immuno-chemotherapy trial for OG Cancer
  A. Chaudry
09.30-10.20 Oral abstract presentations
10.20 - 10.30 Discussion
10.30 - 11.00 Coffee break
11.00 - 12.30 Neoadjuvant  therapy staging and restaging in Esophageal Cancer
  Chairs: M. Spaander, R. Rosati
Bio-molecular and genetic profiling
  S. Mattioli
 11.15-11.30 Cardia carcinoma: challenges in diagnostics and interventions
  C. Bruns
 11.30-11.45 EUS FNA, biopsy bite on bite after neoadjuvant therapy
  M. Spaander
 11.45-12.00 MRI versus PET CT in restaging
  P. van Rossum
12.00-12.20 Oral abstract presentations
12.20-12.30 Discussion
12.30 - 13.30 Lunch
13.30 - 15.30 Surgical Treatment after neoadjuvant therapy in esophageal cancer
  Chairs: M. Hulshof, K. Haustermans

13.30-13.45 Diagnostic genetic markers predicting the response
  T. Underwood
13.45-14.00  The value of Oncologic Lymph node dissection after chemoradiotherapy
  P. Nafteux
14.00-14.30  Debate: Wait and see vs surgery after chemoradiotherapy for esophageal cancer 
  H. Stein vs G. Piessen
14.30-14.45 Salvage Surgery after chemoradiotherapy
  M. van Berge Henegouwen
14.45-15.15 Oral abstract presentations
15.15 - 15.30 Discussion
15.30 - 16.00 Tea break
16.00 - 18.00  Preconditioning and fast recovery in esophageal surgery
  Chair: A. May

16.00-16.30 Debate: Open Surgery is the standard vs MIE is the standard
  M. Griffin vs M. Nilsson
16.30-16.45 Effects of physical exercise during and after cancer treatment
  A. May 
16.45-17.00 Early feeding
  M. Luijer
17.00-17.15 Fast track recovery
  D. Low
17.15-17.30 Prepare for Surgery: Multimodal prehabilitation 
  K. Moorthy 
17.30-17.50          Oral abstract presentations
17.50 - 18.00 Discussion

Click here for abstracts presented as poster

Bening esophageal

08.30-10.30 Oral abstract presentations

Chairs: E. Hazebroek, A. Nieponice

Oral abstract presentations

10.20-10.30 Discussion
10.30-11.00 Coffee break

11.00 - 12.30 Benign esophageal disease: GERD, achalasia and EoE
  Chairs: G. Zaninotto, M. Pera

 11.00-11.15 Optimal methods of determining Achalasia and GERD
  A. Bredenoord
 11.15-11.30 Undoplication versus PPI
  S. Attwood
 11.30-11.45 Anterior vs posterior fundoplication for reflux
  E. Hazebroek
 11.45-12.00 Endostim for new indications
  A. Nieponice
 12.00-12.15 Valvuloplasty: A new concept to treat reflux disease
  F. Gharagozloo
12.15-12.25 Oral abstract presentations
12.25 - 12.30 Discussion
12.30 - 13.30 Lunch
13.30 - 15.30 Benign esophageal: Surgical treatment of GERD and diaphragmatic hernia
  Chairs: K. Fuchs, E. Hazebroek

 13.30-13.45 Treatment of hiatal hernia following esophagectomy
  D. van de Peet
 13.45-14.00 Mesh vs direct repair of hiatal hernia
  G. Zaninotto
 14.00-14.15 Is a fundoplication necessary after hernia repair
  R. Rosati
 14.15-14.30 Long-term follow-up of Manchet trial
  H. Gooszen
14.30-15.20 Oral abstract presentations
15.20 - 15.30 Discussion
15.30 - 16.00 Tea break
16.00 - 18.00 Challenges after paraesophageal hernia repair
  Chairs: I. Broeders, F. Gharagozloo

 16.00-16.15 How to deal with dysphagia
  A. Bredenoord
 16.15-16.30 Robotic Redo surgery after hernia repair
  I. Broeders
 16.30-16.45 The truth about recurrence rates
  K. Fuchs
 16.45-17.00 Dyspeptic complaints and the role of pyloromyotomy
  M. Pera
17.00-17.50 Oral abstract presentations
17.50 - 18.00 Discussion

Click here for abstracts presented as poster